Regulation & law · 26/01/2015Updated: 10/17/2026 · 1 min read
Boehringer Ingelheim Chemical, Inc. Receives DEA Registration for Controlled Substances Manufacturing
Summary
The US Drug Enforcement Administration (DEA) has approved Boehringer Ingelheim Chemical, Inc.'s application to manufacture controlled substances, following a review process
Original source language: Federal Register — Justice DepartmentOpen original release →